Business Description
InventisBio Co Ltd
ISIN : CNE100005Q22
Share Class Description:
SHSE:688382: Class ACompare
Compare
Traded in other countries / regions
688382.China IPO Date
2022-07-25Description
InventisBio Co Ltd is an innovative drug research and development enterprise based in China with a global perspective, focusing on major diseases such as tumors and metabolic diseases. It has independently developed a series of innovative targeted drugs with patent protection, covering non-small cell lung cancer, breast cancer, colorectal cancer and other solid tumors, as well as hyperuricemia and metabolic diseases such as gout.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 176.59 | |||||
| Equity-to-Asset | 0.93 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.04 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 22.75 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EPS without NRI Growth Rate | 39.3 | |||||
| 3-Year FCF Growth Rate | -7.1 | |||||
| 3-Year Book Growth Rate | 16.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.15 | |||||
| 9-Day RSI | 44.31 | |||||
| 14-Day RSI | 44.93 | |||||
| 6-1 Month Momentum % | -46.3 | |||||
| 12-1 Month Momentum % | -55.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 14.99 | |||||
| Quick Ratio | 14.99 | |||||
| Cash Ratio | 13.5 | |||||
| Days Sales Outstanding | 242.4 | |||||
| Days Payable | 6415.1 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7.7 | |||||
| Shareholder Yield % | 0.06 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 97.92 | |||||
| Operating Margin % | -145.79 | |||||
| Net Margin % | -128.41 | |||||
| FCF Margin % | -165.34 | |||||
| ROE % | -12.28 | |||||
| ROA % | -11.49 | |||||
| ROIC % | -260.37 | |||||
| ROC (Joel Greenblatt) % | -424.97 | |||||
| ROCE % | -12.34 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 27.96 | |||||
| PB Ratio | 2.79 | |||||
| Price-to-Tangible-Book | 2.8 | |||||
| EV-to-EBIT | -14.28 | |||||
| EV-to-EBITDA | -14.28 | |||||
| EV-to-Revenue | 18.51 | |||||
| EV-to-FCF | -11.7 | |||||
| Price-to-Net-Current-Asset-Value | 2.85 | |||||
| Price-to-Net-Cash | 3.19 | |||||
| Earnings Yield (Greenblatt) % | -7 | |||||
| FCF Yield % | -5.93 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
InventisBio Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 194.133 | ||
| EPS (TTM) (Â¥) | -0.43 | ||
| Beta | 0 | ||
| Volatility % | 55.07 | ||
| 14-Day RSI | 44.93 | ||
| 14-Day ATR (Â¥) | 0.499968 | ||
| 20-Day SMA (Â¥) | 9.3295 | ||
| 12-1 Month Momentum % | -55.91 | ||
| 52-Week Range (Â¥) | 7.4 - 21.57 | ||
| Shares Outstanding (Mil) | 576.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
InventisBio Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
InventisBio Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
InventisBio Co Ltd Frequently Asked Questions
What is InventisBio Co Ltd(SHSE:688382)'s stock price today?
The current price of SHSE:688382 is ¥9.39. The 52 week high of SHSE:688382 is ¥21.57 and 52 week low is ¥7.40.
When is next earnings date of InventisBio Co Ltd(SHSE:688382)?
The next earnings date of InventisBio Co Ltd(SHSE:688382) is .
Does InventisBio Co Ltd(SHSE:688382) pay dividends? If so, how much?
InventisBio Co Ltd(SHSE:688382) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers